Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Lunai Bioworks Inc.
Report date August 22, 2023 · Filed February 20, 2024
Section 16 reporting ended · disclosed 2024-02-20. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 7,898,482 |
Reported balance
After 2024-02-13 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2024-02-13 · Conversion · Acquired 3,436,190 · Balance 7,898,482 F1: Shares of Series A Convertible Preferred Stock ("Preferred Stock") automatically converted into shares of common stock on a 1-for-10 basis pursuant to their terms upon the closing of the issuer's acquisition of GEDi Cube Int. Ltd. pursuant to that certain Stock Purchase Agreement, dated September 28, 2023, by and among the issuer, GEDi Cube Intl Ltd., the other sellers party thereto, and Yalla Yalla Ltd., in its capacity as the representative of the sellers. F2: The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 7,398,482 |
Reported balance
After 2023-10-03 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2023-10-03 · Grant · Acquired 500,000 · Balance 7,398,482 F2: The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 6,898,482 |
Reported balance
After 2023-08-22 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2023-08-22 · Grant · Acquired 500,000 · Balance 6,898,482 F2: The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer. |
| Series A Convertible Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | IndirectSee Footnote | 0 |
Reported balance
After 2024-02-13 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-02-13 · Conversion · Disposed 343,619 · Balance 0 F3: The Preferred Stock is convertible into common stock on a 1-for-10 basis. F4: The Preferred Stock is perpetual and has no expiration date. F2: The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of Series A Convertible Preferred Stock ("Preferred Stock") automatically converted into shares of common stock on a 1-for-10 basis pursuant to their terms upon the closing of the issuer's acquisition of GEDi Cube Int. Ltd. pursuant to that certain Stock Purchase Agreement, dated September 28, 2023, by and among the issuer, GEDi Cube Intl Ltd., the other sellers party thereto, and Yalla Yalla Ltd., in its capacity as the representative of the sellers.
F2: The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer.
F3: The Preferred Stock is convertible into common stock on a 1-for-10 basis.
F4: The Preferred Stock is perpetual and has no expiration date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2024 Filed Feb 20, 2024 21:20 UTC | Lunai Bioworks Inc. RENB · Entity 7981 | ConversionSeries A Convertible Preferred Stock · Derivative | 343,619 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-015328 · ownership.xml · derivative · entry 4 Abildgaard Ole · CIK 0001994976 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 3,436,190 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Preferred Stock is convertible into common stock on a 1-for-10 basis. F4 · derivative.expiration_date: The Preferred Stock is perpetual and has no expiration date. F2 · ownership.nature: The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer. Read SEC document |
| February 13, 2024 Filed Feb 20, 2024 21:20 UTC | Lunai Bioworks Inc. RENB · Entity 7981 | ConversionCommon Stock | 3,436,190 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-24-015328 · ownership.xml · nonDerivative · entry 1 Abildgaard Ole · CIK 0001994976 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,898,482 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of Series A Convertible Preferred Stock ("Preferred Stock") automatically converted into shares of common stock on a 1-for-10 basis pursuant to their terms upon the closing of the issuer's acquisition of GEDi Cube Int. Ltd. pursuant to that certain Stock Purchase Agreement, dated September 28, 2023, by and among the issuer, GEDi Cube Intl Ltd., the other sellers party thereto, and Yalla Yalla Ltd., in its capacity as the representative of the sellers. F2 · ownership.nature: The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer. Read SEC document |
| October 03, 2023 Filed Feb 20, 2024 21:20 UTC | Lunai Bioworks Inc. RENB · Entity 7981 | GrantCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-015328 · ownership.xml · nonDerivative · entry 2 Abildgaard Ole · CIK 0001994976 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,398,482 F2 · ownership.nature: The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer. Read SEC document |
| August 22, 2023 Filed Feb 20, 2024 21:20 UTC | Lunai Bioworks Inc. RENB · Entity 7981 | GrantCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-015328 · ownership.xml · nonDerivative · entry 3 Abildgaard Ole · CIK 0001994976 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 6,898,482 F2 · ownership.nature: The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.